65. Primary immunodeficiency Clinical trials / Disease details

Clinical trials : 500 / Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00187057 (ClinicalTrials.gov)	September 2002	12/9/2005	Study for Treatment of Cancer in Children With Ataxia-telangiectasia	Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia	Ataxia-Telangiectasia	Drug: vinblastine , vincristine, prednisone, daunorubicin;Drug: doxorubicin , methotrexate, cyclophosphamide, L-asparaginase;Drug: etoposide , cytarabine, mercaptopurine;Drug: dexamethasone , procarbazine;Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy	St. Jude Children's Research Hospital	Children's Hospital of Philadelphia;National Cancer Institute (NCI)	Completed	N/A	10 Years	Both	6	N/A	United States
2	NCT00006054 (ClinicalTrials.gov)	March 2000	5/7/2000	Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies		Immunologic Deficiency Syndromes;Chediak-Higashi Syndrome;Common Variable Immunodeficiency;Graft Versus Host Disease;X-Linked Lymphoproliferative Syndrome;Familial Erythrophagocytic Lymphohistiocytosis;Hemophagocytic Lymphohistiocytosis;X-linked Agammaglobulinemia;Wiskott-Aldrich Syndrome;Chronic Granulomatous Disease;X-linked Hyper IgM Syndrome;Severe Combined Immunodeficiency;Leukocyte Adhesion Deficiency Syndrome;Virus-Associated Hemophagocytic Syndrome	Drug: anti-thymocyte globulin;Drug: busulfan;Drug: cyclophosphamide;Drug: cyclosporine;Drug: etoposide;Drug: methotrexate;Drug: methylprednisolone;Drug: prednisone;Procedure: Allogeneic Bone Marrow Transplantation	Fairview University Medical Center	NULL	Terminated	N/A	35 Years	Both		N/A	United States